BioPharmX

@biopharmx

BioPharmX Corporation (NYSE American: ) is a specialty pharmaceutical company focused on optimizing drug delivery to benefit dermatology patients worldwide

Vrijeme pridruživanja: veljača 2014.

Medijski sadržaj

  1. 16. lis 2018.

    Though this article still refers to the old four subtypes, this is a great roundup describing , a condition that affects an estimated 415 million people worldwide!

  2. 11. lis 2018.

    BioPharmX initiates phase 2b trial of BPX-04 for

  3. 8. lis 2018.
  4. 30. kol 2018.

    Dr. Neal Bhatia, talks new rosacea phenotype classifications, antibiotic resistance, and the attractiveness of new drugs in development, including BPX-04, for the treatment of . via

  5. 22. kol 2018.

    BioPharmX EVP of R&D, Kin Chan, PhD, reiterates the need in for new, effective topical drugs that offer therapeutic breakthroughs for in his article spotlighting the patented delivery system.

  6. 13. kol 2018.

    Are you still receiving automated calls reminding you to vote in advance of tomorrow's shareholder meeting, but have already voted? This might be because you hold more than one position or have multiple accounts. Please be sure to vote all your positions/accounts.

  7. 9. kol 2018.

    BioPharmX announces patent award, expanding protection for innovations in solid dosage forms

  8. 27. srp 2018.

    The BioPharmX BoD encourages shareholders to vote in favor of the proposed amendments in time for the upcoming Annual Shareholder Meeting (8/14).

  9. 20. srp 2018.

    NPs and PAs are at the heart of , which is why this audience is eager to learn more about the post hoc analysis data of BPX-01 in females with at .

  10. 27. lip 2018.
  11. 21. lip 2018.

    Study on the staining effects of benzoyl peroxide (BPO), an established treatment option for , suggests BPO's discoloration is worst on cotton fabrics.

  12. 11. lip 2018.

    survey at the @TwinsDayFest and published in the Journal of Drugs in Dermatology affirms a genetic link for the skin condition.

  13. 7. lip 2018.

    BioPharmX Reports First Quarter 2019 Financial Results

  14. 6. lip 2018.

    can affect more than just how you look. Actress shares how acne affected her self-image and how it developed into social anxiety and even slight body dysmorphia. via

  15. 4. lip 2018.

    We are pleased to update investors of that as of June 1, the company is back in compliance with the NYSE American’s continued listing standards.

  16. 1. lip 2018.

    June is . Follow BioPharmX on Facebook and Twitter as we create awareness and share all the latest news and stories about this skin condition that can subject patients to tremendous social anxiety.

  17. 2. svi 2018.

    We love this infographic from showing its process. uses already approved APIs to bring new drugs to market, helping minimize time and cost.

  18. 27. tra 2018.

    April 28th is Prescription Drug Take Back Day. Find out where you can dispose of unused drugs.

  19. 26. tra 2018.

    BioPharmX reports Q4 and FY 2018 financial results

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·